Synopsis
Synopsis
0
API Suppliers
 
																							0
USDMF
 
																							0
CEP/COS
 
																							0
JDMF
 
																							0
EU WC
 
																							0
KDMF
 
																							0
NDC API
 
																							0
VMF
 
																							0
Listed Suppliers
 
																							0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
 
																							0
FDA Orange Book
 
																							0
Europe
 
																							0
Canada
 
																							0
Australia
 
																							0
South Africa
 
																							0
Listed Dossiers
 
																							
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid 
NA
Annual Reports 
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. 4-((l-valyl)oxy)butanoic Acid
2. Xwl-008
3. Xw10172
4. 9b8nwp8k91
5. L-valine, 3-carboxypropyl Ester
6. Xw-10172
7. Refchem:1100924
8. Valiloxibic Acid
9. 238401-16-6
10. Valiloxybate [usan]
11. Valiloxybate (usan)
12. 4-[(2s)-2-amino-3-methylbutanoyl]oxybutanoic Acid
13. Starbld0003028
14. Valiloxybate [inn]
15. Unii-9b8nwp8k91
16. Orb1690933
17. Schembl3730354
18. Chembl5095201
19. Who 11367
20. Akos040757642
21. Da-58947
22. Ms-23099
23. Hy-137429
24. Cs-0138627
25. D12240
26. G18491
27. 4-{[(2s)-2-amino-3-methylbutanoyl]oxy}butanoic Acid
| Molecular Weight | 203.24 g/mol | 
|---|---|
| Molecular Formula | C9H17NO4 | 
| XLogP3 | -1.9 | 
| Hydrogen Bond Donor Count | 2 | 
| Hydrogen Bond Acceptor Count | 5 | 
| Rotatable Bond Count | 7 | 
| Exact Mass | Da | 
| Monoisotopic Mass | Da | 
| Topological Polar Surface Area | 89.6 | 
| Heavy Atom Count | 14 | 
| Formal Charge | 0 | 
| Complexity | 203 | 
| Isotope Atom Count | 0 | 
| Defined Atom Stereocenter Count | 1 | 
| Undefined Atom Stereocenter Count | 0 | 
| Defined Bond Stereocenter Count | 0 | 
| Undefined Bond Stereocenter Count | 0 | 
| Covalently Bonded Unit Count | 1 | 
ABOUT THIS PAGE
